50 years of oral lipid-based formulations: provenance, progress and future perspectives
Open accessAbstract
Lipid based formulations (LBF) provide well proven opportunities to enhance the oral absorption of drugs and drug candidates that sit close to, or beyond, the boundaries of Lipinski's 'rule-of-five' chemical space. Advantages in permeability, efflux and presystemic metabolism are evident; however, the primary benefit is in increases in dissolution and apparent intestinal solubility for lipophilic, poorly water soluble drugs. This review firstly details the inherent advantages of LBF, their general properties and classification, and provides a brief retrospective assessment of the development of LBF over the past fifty years. More detailed analysis of the ability of LBF to promote intestinal solubilisation, supersaturation and absorption is then provided alongside review of the methods employed to assess formulation performance. Critical review of the ability of simple dispersion and more complex in vitro digestion methods to predict formulation performance subsequently reveals marked differences in the correlative ability of in vitro tests, depending on the properties of the drug involved. Notably, for highly permeable low melting drugs e.g. fenofibrate, LBF appear to provide significant benefit in all cases, and sustained ongoing solubilisation may not be required. In other cases, and particularly for higher melting point drugs such as danazol, where re-dissolution of crystalline precipitate drug is likely to be slow, correlations with ongoing solubilisation and supersaturation are more evident. In spite of their potential benefits, one limitation to broader use of LBF is low drug solubility in the excipients employed to generate formulations. Techniques to increase drug lipophilicity and lipid solubility are therefore explored, and in particular those methods that provide for temporary enhancement including lipophilic ionic liquid and prodrug technologies. The transient nature of these lipophilicity increases enhances lipid solubility and LBF viability, but precludes enduring effects on receptor promiscuity and off target toxicity. Finally, recent efforts to generate solid LBF are briefly described as a means to circumvent the need to encapsulate in soft or hard gelatin capsules, although the latter remain popular with consumers and a proven means of LBF delivery.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A limited number (50%) of in vitro-in vivo correlations have been observed for lipid-based drug delivery systems based on comparing drug solubilisation in the aqueous phase of the digestion medium from the standard in vitro lipolysis model and in vivo drug absorption.
“Despite the advances in optimising digestion conditions to more closely match the in vivo scenario, overall a limited number (50%) of in vitro -in vivo correlations (IVIVC) have been observed for LBDDS based on comparing drug solubilisation in the aqueous phase of the digestion medium from the standard in vitro lipolysis model and the in vivo drug absorption (Feeney et al., 2016).”
From Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption (2020) · cites this paper as Feeney et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484 · see citing works
Applications of ionic liquids in the chemical industry
Plechkova, N. V., & Seddon, K. R. (2008) · Chem. Soc. Rev. · doi:10.1039/b006677j · Cited by 5,686 · see citing works
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523 · see citing works
Ionic Liquids--Solvents of the Future?
Rogers, R. D., & Seddon, K. R. (2003) · Science · doi:10.1126/science.1090313 · Cited by 4,140 · see citing works
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824 · see citing works
Self-citationProdrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,645 · see citing works
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R. A., & Hanes, J. S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,630 · see citing works
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,582 · see citing works
Self-citationSalt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,443 · see citing works
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,417 · see citing works
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R. A. E., Murray, C. W., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,365 · see citing works
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Gürsoy, R. N., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358 · see citing works
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,306 · see citing works
Self-citationPouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,232 · see citing works
Self-citationPhysical Properties of Ionic Liquids: Database and Evaluation
Zhang, S., Sun, N., He, X., Lü, X., & Zhang, X. (2006) · Journal of Physical and Chemical Reference Data · doi:10.1063/1.2204959 · Cited by 1,224 · see citing works
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,058 · see citing works
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E. L., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 995 · see citing works
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 973 · see citing works
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 948 · see citing works
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 912 · see citing works
Pouton, C. W., & Porter, C. J. H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 887 · see citing works
Self-citationLipid Digestion and Absorption
Carey, M. C., SMALL, D. M., & Bliss, C. M. (1983) · Annual Review of Physiology · doi:10.1146/annurev.ph.45.030183.003251 · Cited by 876 · see citing works
Constantinides, P. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016268311867 · Cited by 743 · see citing works
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuiné, J. F., & Charman, W. N. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 692 · see citing works
Self-citationFrom Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654 · see citing works
Self-citationThe digestion of dietary triacylglycerols
Mu, H. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00050-x · Cited by 636 · see citing works
Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
Anton, N., & Vandamme, T. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0309-1 · Cited by 624 · see citing works
Hauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 597 · see citing works
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
Humberstone, A., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00494-2 · Cited by 578 · see citing works
Self-citationOptimized conditions for prediction of intestinal drug permeability using Caco-2 cells
Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., & Tokuda, H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00076-2 · Cited by 570 · see citing works
Shah, N. H., Carvajal, M. T., Patel, C., Infeld, M. H., & Malick, A. W. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90271-2 · Cited by 483 · see citing works
Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs
Gershanik, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00089-8 · Cited by 476 · see citing works
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy‐Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 408 · see citing works
Physical chemistry of supersaturated solutions and implications for oral absorption
Taylor, L. S., & Zhang, G. G. Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.006 · Cited by 398 · see citing works
Approaches for the development of solid and semi-solid lipid-based formulations
Jannin, V., Musakhanian, J., & Marchaud, D. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.006 · Cited by 389 · see citing works
Patton, J. S., & Carey, M. C. (1979) · Science · doi:10.1126/science.432636 · Cited by 385 · see citing works
Charman, S. A., Charman, W. N., Rogge, M. C., Wilson, T. D., Dutko, F. J., & Pouton, C. W. (1992) · Pharmaceutical Research · doi:10.1023/a:1018987928936 · Cited by 378 · see citing works
Self-citationIn vitro models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Abrahamsson, B., Brewster, M. E., Brouwers, J., Butler, J., Carlert, S., Dickinson, P. A., Dressman, J., Holm, R., Klein, S., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.024 · Cited by 376 · see citing works
ABSORPTION OF DRUGS FROM THE RAT SMALL INTESTINE
Schanker, L. S., Tocco, D. J., Brodie, B. B., & Hogben, C. A. M. (1958) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12018-1 · Cited by 373 · see citing works
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372 · see citing works
Gao, P., Rush, B. D., Pfund, W. P., Huang, T., Bauer, J. M., Morozowich, W., Kuo, M., & Hageman, M. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10511 · Cited by 360 · see citing works
Crystalline vs. Ionic Liquid Salt Forms of Active Pharmaceutical Ingredients: A Position Paper
Stoimenovski, J., MacFarlane, D. R., Bica, K., & Rogers, R. D. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0030-0 · Cited by 359 · see citing works
Intestinal lymphatic drug transport: an update
Porter, C. J. H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 338 · see citing works
Self-citationLindmark, T., Kimura, Y., & Artursson, P. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37216-7 · Cited by 333 · see citing works
The Digestion and Absorption of Triglycerides
Mattson, F. H., & Volpenhein, R. A. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93813-5 · Cited by 327 · see citing works
Maisel, K., Ensign, L. M., Reddy, M., Cone, R. A., & Hanes, J. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 320 · see citing works
Hauss, D. J., Fogal, S. E., FICORILLI, J. V., Price, C. A., Roy, T., Jayaraj, A. A., & Keirns, J. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970300n · Cited by 316 · see citing works
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309 · see citing works
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J. F., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307 · see citing works
Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport
Crater, J. S., & Carrier, R. L. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000137 · Cited by 303 · see citing works
Curatolo, W. J., Nightingale, J., & Herbig, S. M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9852-z · Cited by 300 · see citing works
Aguirre, T. A. S., Teijeiro‐Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.004 · Cited by 300 · see citing works
Müllertz, A., Ogbonna, A., Ren, S., & Rades, T. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01107.x · Cited by 295 · see citing works
Aungst, B. J. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600821008 · Cited by 295 · see citing works
Kovarik, J. M., Mueller, E. A., Kutz, K., van Bree, J. B., & Tetzloff, W. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830336 · Cited by 295 · see citing works
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Kristensen, H. G., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00169-5 · Cited by 287 · see citing works
Mucus as a barrier to lipophilic drugs
Sigurðsson, H. H., Kirch, J., & Lehr, C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.040 · Cited by 280 · see citing works
Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Tetzloff, W., Grevel, J., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018923912135 · Cited by 275 · see citing works
Williams, H. D., Sassene, P. J., Kleberg, K., N’Goma, J. B., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23205 · Cited by 274 · see citing works
Self-citationSpeybroeck, M. V., Barillaro, V., Thi, T. D., Mellaerts, R., Martens, J. A., Humbeeck, J. V., Vermant, J., Annaert, P., den Mooter, G. V., & Augustijns, P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21638 · Cited by 272 · see citing works
Miller, J. M., Beig, A., Carr, R. A., Spence, J. K., & Dahan, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300104s · Cited by 257 · see citing works
Spiller, R. E., Trotman, I. F., Adrian, T. E., Bloom, S. R., Misiewicz, J. J., & Silk, D. B. A. (1988) · Gut · doi:10.1136/gut.29.8.1042 · Cited by 255 · see citing works
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K. J., Brewster, M. E., Dressman, J., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 255 · see citing works
Self-citationSelf-emulsifying drug delivery systems: assessment of the efficiency of emulsification
Pouton, C. W. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90081-x · Cited by 253 · see citing works
Self-citationEvaluation of gastrointestinal drug supersaturation and precipitation: Strategies and issues
Bevernage, J., Brouwers, J., Brewster, M. E., & Augustijns, P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.026 · Cited by 252 · see citing works
Kovarik, J. M., Mueller, E. A., van Bree, J. B., FLÜCKIGER, S. S., LANGE, H., SCHMIDT, B., Boesken, W. H., Lison, A. E., & Kutz, K. (1994) · Transplantation · doi:10.1097/00007890-199409000-00004 · Cited by 246 · see citing works
Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions
Riethorst, D., Mols, R., Duchateau, G. S. M. J. E., Tack, J. F., Brouwers, J., & Augustijns, P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24603 · Cited by 245 · see citing works
Porter, C. J. H., Kaukonen, A. M., Boyd, B. J., Edwards, G. A., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036914.22132.cc · Cited by 243 · see citing works
Self-citationCole, E. T., Cadé, D., & Benameur, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.009 · Cited by 241 · see citing works
Room temperature ionic liquids and their mixtures: Potential pharmaceutical solvents
Mizuuchi, H., Jaitely, V., Murdan, S., & Florence, A. T. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.01.002 · Cited by 241 · see citing works
Chemistry: Develop ionic liquid drugs
Shamshina, J. L., Kelley, S. P., Gurău, G., & Rogers, R. D. (2015) · Nature · doi:10.1038/528188a · Cited by 235 · see citing works
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5
Kuminek, G., Cao, F., da Rocha, A. B. D. O., Cardoso, S. G., & Rodríguez‐Hornedo, N. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.022 · Cited by 235 · see citing works
Dahan, A., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.017 · Cited by 232 · see citing works
Béduneau, A., Tempesta, C., Fimbel, S., Pellequer, Y., Jannin, V., Demarne, F., & Lamprecht, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.017 · Cited by 227 · see citing works
Pluronics and MDR reversal: an update
Alakhova, D. Y., & Kabanov, A. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500298q · Cited by 224 · see citing works
Anderberg, E. K., Lindmark, T., & Artursson, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018909210879 · Cited by 221 · see citing works
Influence of lipolysis on drug absorption from the gastro-intestinal tract
MacGregor, K. J., Embleton, J. K., Lacy, J. E., Perry, E., Solomon, L. J., Seager, H., & Pouton, C. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00489-9 · Cited by 220 · see citing works
Self-citationIlevbare, G. A., Liu, H., Edgar, K. J., & Taylor, L. S. (2012) · Crystal Growth & Design · doi:10.1021/cg300325p · Cited by 218 · see citing works
Porter, C. J. H., Kaukonen, A. M., Taillardat‐Bertschinger, A., Boyd, B. J., O'Connor, J. M., Edwards, G. A., & Charman, W. N. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20039 · Cited by 216 · see citing works
Self-citationThomas, N., Holm, R., Müllertz, A., & Rades, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.027 · Cited by 215 · see citing works
Constantinides, P. P., & Wasan, K. M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20780 · Cited by 209 · see citing works
Gao, P., Guyton, M. E., Huang, T., Bauer, J. M., Stefanski, K. J., & Lu, Q. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120028718 · Cited by 209 · see citing works
Greenberger, N. J., Rodgers, J. B., & Isselbacher, K. J. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105334 · Cited by 207 · see citing works
Bica, K., Rijksen, C., Nieuwenhuyzen, M., & Rogers, R. D. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/b923855g · Cited by 206 · see citing works
Psachoulias, D., Vertzoni, M., Goumas, K., Kalioras, V., Beato, S., Butler, J., & Reppas, C. I. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0506-6 · Cited by 206 · see citing works
Miller, J. M., Beig, A., Krieg, B. J., Carr, R. A., Borchardt, T. B., Amidon, G. E., Amidon, G. L., & Dahan, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200181v · Cited by 204 · see citing works
Kossena, G. A., Boyd, B. J., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10329 · Cited by 199 · see citing works
Self-citationDahan, A., & Hoffman, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9054-x · Cited by 195 · see citing works
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Kristensen, H. G., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00182-8 · Cited by 194 · see citing works
Johnson, B. M., Charman, W. N., & Porter, C. J. H. (2002) · AAPS PharmSci · doi:10.1208/ps040440 · Cited by 194 · see citing works
Self-citationComputational prediction of formulation strategies for beyond-rule-of-5 compounds
Bergström, C. A. S., Charman, W. N., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.005 · Cited by 190 · see citing works
Self-citationHu, M., Li, Y., Decker, E. A., & McClements, D. J. (2010) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2010.03.010 · Cited by 186 · see citing works
Bogman, K., Erne-Brand, F., Alsenz, J., & Drewe, J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10395 · Cited by 184 · see citing works
Crounse, R. G. (1961) · Journal of Investigative Dermatology · doi:10.1038/jid.1961.154 · Cited by 184 · see citing works
Cuiné, J. F., McEvoy, C. L., Charman, W. N., Pouton, C. W., Edwards, G. A., Benameur, H., & Porter, C. J. H. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21246 · Cited by 177 · see citing works
Self-citationSek, L., Porter, C. J. H., & Charman, W. N. (2001) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(00)00528-8 · Cited by 176 · see citing works
Self-citationLi, S., Wong, S., Sethia, S., Almoazen, H., Joshi, Y. M., & Serajuddin, A. T. M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2504-z · Cited by 175 · see citing works
Wilson, F. A., Sallee, V. L., & Dietschy, J. M. (1971) · Science · doi:10.1126/science.174.4013.1031 · Cited by 172 · see citing works
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Grevel, J., Lücker, P. W., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018922517162 · Cited by 170 · see citing works
Tan, A., Rao, S., & Prestidge, C. A. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1107-3 · Cited by 168 · see citing works
Sahbaz, Y., Williams, H. D., Nguyen, T., Saunders, J., Ford, L., Charman, S. A., Scammells, P. J., & Porter, C. J. H. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500790t · Cited by 167 · see citing works
Self-citationGao, P., Akrami, A., Alvarez, F., Hu, J., Li, L., Ma, C., & Surapaneni, S. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21451 · Cited by 166 · see citing works
N'Goma, J.-C. B., Amara, S., Dridi, K., Jannin, V., & Carrière, F. (2012) · Therapeutic delivery · doi:10.4155/tde.11.138 · Cited by 160 · see citing works
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
Ingels, F., Beck, B., Oth, M., & Augustijns, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.014 · Cited by 155 · see citing works
Cuiné, J. F., Charman, W. N., Pouton, C. W., Edwards, G. A., & Porter, C. J. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9194-z · Cited by 154 · see citing works
Self-citationAnby, M. U., Williams, H. D., McIntosh, M. P., Benameur, H., Edwards, G. A., Pouton, C. W., & Porter, C. J. H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300164u · Cited by 154 · see citing works
Self-citationNielsen, F. S., Petersen, K. B., & Müllertz, A. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.12.020 · Cited by 154 · see citing works
Prodrugs : challenges and rewards
Stella, V. J. (2007) · Cited by 153 · see citing works
Sassene, P. J., Knopp, M. M., Hesselkilde, J. Z., Koradia, V., Larsen, A. T., Rades, T., & Müllertz, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22226 · Cited by 149 · see citing works
Khoo, S., Shackleford, D. M., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (2003) · Pharmaceutical Research · doi:10.1023/a:1025718513246 · Cited by 147 · see citing works
Self-citationDynamic Dissolution: A Step Closer to Predictive Dissolution Testing?
McAllister, M. S. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001203 · Cited by 145 · see citing works
Williams, H. D., Sahbaz, Y., Ford, L., Nguyen, T., Scammells, P. J., & Porter, C. J. H. (2013) · Chemical Communications · doi:10.1039/c3cc48650h · Cited by 143 · see citing works
Self-citationEffect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability
Charman, W. N., Rogge, M. C., Boddy, A. W., & Berger, B. M. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb04673.x · Cited by 141 · see citing works
Self-citationAqueous lipid phases of relevance to intestinal fat digestion and absorption
Lindström, M., Ljusberg‐Wahren, H., Larsson, K., & Borgström, B. (1981) · Lipids · doi:10.1007/bf02535343 · Cited by 141 · see citing works
Boegh, M., Baldursdóttir, S., Müllertz, A., & Nielsen, H. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.01.001 · Cited by 141 · see citing works
Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs
Gao, P., & Shi, Y. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9389-7 · Cited by 137 · see citing works
Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption
Attili-Qadri, S., Karra, N., Nemirovski, A., Schwob, O., Talmon, Y., Nassar, T., & Benita, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313839110 · Cited by 135 · see citing works
Uptake of drugs into the intestinal lymphatics after oral administration
Porter, C. J. H., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00492-9 · Cited by 135 · see citing works
Self-citationMiller, J. M., Beig, A., Carr, R. A., Webster, G. K., & Dahan, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200460u · Cited by 134 · see citing works
Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3
Fuchs, A., Leigh, M. L. S., Kloefer, B., & Dressman, J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.015 · Cited by 133 · see citing works
The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
Akhtar, N., Ahad, A., Khar, R. K., Jaggi, M., Aqil, M., Iqbal, Z., Ahmad, F. J., & Talegaonkar, S. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.561784 · Cited by 133 · see citing works
Stella, V. J., Tilley, J., Oliyai, R., Maag, H., Hageman, M. J., & Borchardt, R. T. (2007) · Springer eBooks · doi:10.1007/978-0-387-49785-3 · Cited by 131 · see citing works
Kossena, G. A., Charman, W. N., Boyd, B. J., Dunstan, D. E., & Porter, C. J. H. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10554 · Cited by 129 · see citing works
Self-citationDissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS)
Agarwal, V., Siddiqui, A., Ali, H., & Nazzal, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.046 · Cited by 129 · see citing works
Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man
Horst, H.-J., H�ltje, W. J., Dennis, M. J., Coert, A., Geelen, J., & Voigt, K. D. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01483589 · Cited by 128 · see citing works
Williams, H. D., Anby, M. U., Sassene, P. J., Kleberg, K., N’Goma, J. B., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300331z · Cited by 128 · see citing works
Self-citationGriffin, B. T., Kuentz, M., Vertzoni, M., Kostewicz, E. S., Fei, Y., Faisal, W., Stillhart, C., O’Driscoll, C. M., Reppas, C., & Dressman, J. B. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.10.016 · Cited by 126 · see citing works
Fernandez, S., Jannin, V., Rodier, J.-D., Ritter, N., Mahler, B., & Carrière, F. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.009 · Cited by 126 · see citing works
Structure and function of gastro-intestinal lipases
Embleton, J. K., & Pouton, C. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00488-7 · Cited by 126 · see citing works
Self-citationComputational Prediction of Drug Solubility in Lipid Based Formulation Excipients
Persson, L. C., Porter, C. J. H., Charman, W. N., & Bergström, C. A. S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1083-7 · Cited by 125 · see citing works
Self-citationWilliams, H. D., Trevaskis, N. L., Yeap, Y. Y., Anby, M. U., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1126-0 · Cited by 123 · see citing works
Self-citationThe effects of pharmaceutical excipients on drug disposition
Buggins, T. R., Dickinson, P. A., & Taylor, G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.017 · Cited by 122 · see citing works
Kaukonen, A. M., Boyd, B. J., Charman, W. N., & Porter, C. J. H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016283.87709.a9 · Cited by 121 · see citing works
Self-citationComparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug delivery
Ahern, R. J., Hanrahan, J. P., Tobin, J. M., Ryan, K. B., & Crean, A. M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.026 · Cited by 120 · see citing works
Shi, Y., Gao, P., Gong, Y., & Ping, H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100114a · Cited by 120 · see citing works
Abdalla, A., Klein, S., & Mäder, K. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.09.006 · Cited by 119 · see citing works
Solubilizing Properties of Bile Salt Solutions I
Bates, T. R., Gibaldi, M., & Kanig, J. L. (1966) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600550213 · Cited by 117 · see citing works
An examination of the factors affecting intestinal lymphatic transport of dietary lipids
Nordskog, B. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00147-8 · Cited by 116 · see citing works
Carrigan, P. J., & Bates, T. R. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600620918 · Cited by 116 · see citing works
Shackleford, D. M., Faassen, W. A., Houwing, N. S., Lass, H., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052522 · Cited by 113 · see citing works
Self-citationThomas, N., Richter, K., Pedersen, T. B., Holm, R., Müllertz, A., & Rades, T. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9589-4 · Cited by 111 · see citing works
Characterising Lipid Lipolysis and Its Implication in Lipid-Based Formulation Development
Thomas, N., Holm, R., Rades, T., & Müllertz, A. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9398-6 · Cited by 111 · see citing works
Low Dose Lipid Formulations: Effects on Gastric Emptying and Biliary Secretion
Kossena, G. A., Charman, W. N., WILSON, C. G., O’Mahony, B., Lindsay, B., Hempenstall, J., Davison, C. L., Crowley, P., & Porter, C. J. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9363-8 · Cited by 109 · see citing works
Self-citationEffect of excipients on breast cancer resistance protein substrate uptake activity
Yamagata, T., Kusuhara, H., Morishita, M., Takayama, K., Benameur, H., & Sugiyama, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.021 · Cited by 108 · see citing works
The effect of oils on the lymphatic absorption of DDT
Palin, K. J., WILSON, C. G., Davis, S. S., & Phillips, A. J. (1982) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1982.tb06204.x · Cited by 107 · see citing works
Fuchs, A., & Dressman, J. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24183 · Cited by 106 · see citing works
Reineke, J., Cho, D., Dingle, Y. L., Morello, A. P., Jacob, J. S., Thanos, C. G., & Mathiowitz, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305882110 · Cited by 105 · see citing works
Freeman, C. (1969) · British Journal Of Nutrition · doi:10.1079/bjn19690032 · Cited by 105 · see citing works
Chiu, Y.-Y., Higaki, K., Neudeck, B. L., Barnett, J. L., Welage, L. S., & Amidon, G. L. (2003) · Pharmaceutical Research · doi:10.1023/a:1023481418576 · Cited by 105 · see citing works
CYCLOSPORINE INCREASES THE OXIDIZABILITY OF LOW-DENSITY LIPOPROTEINS IN RENAL TRANSPLANT RECIPIENTS
APANAY, D. C., NEYLAN, J. F., Ragab, M., & Sgoutas, D. S. (1994) · Transplantation · doi:10.1097/00007890-199409000-00005 · Cited by 105 · see citing works
Williams, H. D., Sassene, P. J., Kleberg, K., Calderone, M., Igonin, A., Jule, E., Vertommen, J., Blundell, R., Benameur, H., Müllertz, A., et al. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1038-z · Cited by 104 · see citing works
Self-citationSosnik, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.002 · Cited by 104 · see citing works
Simović, S., Heard, P. J., He, H. Z., Song, Y., Peddie, F., Davey, A. K., Lewis, A., Rades, T., & Prestidge, C. A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900063t · Cited by 103 · see citing works
Fischer, S. M., Brandl, M., & Fricker, G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.010 · Cited by 100 · see citing works
The effect of different oils on the absorption of probucol in the rat
Palin, K. J., & WILSON, C. G. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb04919.x · Cited by 99 · see citing works
THE PHARMACOLOGY AND METABOLISM OF TESTOSTERONE UNDECANOATE (TU), A NEW ORALLY ACTIVE ANDROGEN
Coert, A., Geelen, J., de Visser, J., & van der Vies, J. (1975) · European Journal of Endocrinology · doi:10.1530/acta.0.0790789 · Cited by 99 · see citing works
Sander, C., & Holm, P. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9340-0 · Cited by 99 · see citing works
Larsen, A. T., Ohlsson, A. G., Polentarutti, B. I., Barker, R. A., Phillips, A. R., Abu-Rmaileh, R., Dickinson, P. A., Abrahamsson, B., Østergaard, J., & Müllertz, A. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.004 · Cited by 98 · see citing works
Goindi, S., Kaur, R., & Kaur, R. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.066 · Cited by 97 · see citing works
Vors, C., Capolino, P., Guérin, C., Meugnier, E., Pesenti, S., Chauvin, M., Monteil, J., Peretti, N., Cansell, M., Carrière, F., et al. (2012) · Food & Function · doi:10.1039/c2fo10248j · Cited by 95 · see citing works
Solvent-Free Melting Techniques for the Preparation of Lipid-Based Solid Oral Formulations
Becker, K., Salar-Behzadi, S., & Zimmer, A. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1661-y · Cited by 95 · see citing works
Tools for Early Prediction of Drug Loading in Lipid-Based Formulations
Alskär, L. C., Porter, C. J. H., & Bergström, C. A. S. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00704 · Cited by 94 · see citing works
Self-citationHan, S., Quach, T., Hu, L., Wahab, A., Charman, W. N., Stella, V. J., Trevaskis, N. L., Simpson, J. S., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.031 · Cited by 93 · see citing works
Self-citationFernandez, S., Chevrier, S., Ritter, N., Mahler, B., Demarne, F., Carrière, F., & Jannin, V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9906-2 · Cited by 91 · see citing works
Gumaste, S. G., Dalrymple, D. M., & Serajuddin, A. T. M. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1106-4 · Cited by 91 · see citing works
Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro
Christiansen, A., Backensfeld, T., Denner, K., & Weitschies, W. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.033 · Cited by 91 · see citing works
Beloqui, A., Solinís, M. Á., Rieux, A. D., Véronique Préat, A., & Rodríguez‐Gascón, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.027 · Cited by 91 · see citing works
Formation of Highly Organized Nanostructures during the Digestion of Milk
Salentinig, S., Phan, S., Khan, J., Hawley, A. M., & Boyd, B. J. (2013) · ACS Nano · doi:10.1021/nn405123j · Cited by 90 · see citing works
KOGA, K., Kusawake, Y., ITO, Y., Sugioka, N., SHIBATA, N., & TAKADA, K. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.03.011 · Cited by 90 · see citing works
Feeney, O. M., Williams, H. D., Pouton, C. W., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.037 · Cited by 88 · see citing works
Self-citationSulfasalazine in ionic liquid form with improved solubility and exposure
Shadid, M., Gurău, G., Shamshina, J. L., Chuang, B.-C., Hailu, S., Guan, E., Chowdhury, S. K., Wu, J., Rizvi, S. A. A., Griffin, R., et al. (2015) · MedChemComm · doi:10.1039/c5md00290g · Cited by 87 · see citing works
In Vitro Model for Ciclosporin Intestinal Absorption in Lipid Vehicles
Reymond, J.-P., & Sucker, H. (1988) · Pharmaceutical Research · doi:10.1023/a:1015987223407 · Cited by 86 · see citing works
Poelma, F. G. J., Breäs, R., Tukker, J. J., & Crommelin, D. J. A. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb06697.x · Cited by 85 · see citing works
Myers, R. A., & Stella, V. J. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90374-b · Cited by 84 · see citing works
In situ perfusion in rodents to explore intestinal drug absorption: Challenges and opportunities
Stappaerts, J., Brouwers, J., Annaert, P., & Augustijns, P. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.035 · Cited by 84 · see citing works
Kataoka, M., Sugano, K., Mathews, C. D. C., Wong, J. W., Jones, K. L., Masaoka, Y., Sakuma, S., & Yamashita, S. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0623-2 · Cited by 84 · see citing works
Yeap, Y. Y., Trevaskis, N. L., Quach, T., Tso, P., Charman, W. N., & Porter, C. J. H. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3006566 · Cited by 83 · see citing works
Self-citationSpeybroeck, M. V., Williams, H. D., Nguyen, T., Anby, M. U., Porter, C. J. H., & Augustijns, P. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300298z · Cited by 83 · see citing works
Self-citationShukla, D., Chakraborty, S., Singh, S., & Mishra, B. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.547469 · Cited by 82 · see citing works
Enhancement of the oral absorption of cyclosporin in man.
Drewe, J., Meier, R. F., Vonderscher, J., Kiss, D., Posanski, U., Kissel, T., & Gyr, K. E. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04108.x · Cited by 80 · see citing works
Ozaki, S., Minamisono, T., Yamashita, T., Kato, T., & Kushida, I. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22760 · Cited by 80 · see citing works
Ritschel, W. A. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00458.x · Cited by 79 · see citing works
Self-Emulsification of Vegetable Oil-Nonionic Surfactant Mixtures
Wakerly, M. G., Pouton, C. W., Meakin, B. J., & Morton, F. (1986) · ACS symposium series · doi:10.1021/bk-1986-0311.ch018 · Cited by 79 · see citing works
Self-citationBoegh, M., García-Díaz, M., Müllertz, A., & Nielsen, H. M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.014 · Cited by 78 · see citing works
Food-associated stimuli enhance barrier properties of gastrointestinal mucus
Yıldız, H., Speciner, L., Ozdemir, C., Cohen, D. E., & Carrier, R. L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.118 · Cited by 77 · see citing works
Trull, A. K., Tan, K., Tan, L., Alexander, G., & Jamieson, N. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05722.x · Cited by 77 · see citing works
Bates, T. R., & Sequeira, J. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640513 · Cited by 76 · see citing works
Tan, A., Eskandar, N. G., Rao, S., & Prestidge, C. A. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0172-9 · Cited by 76 · see citing works
Álvarez, F. J., & Stella, V. J. (1989) · Pharmaceutical Research · doi:10.1023/a:1015956104500 · Cited by 76 · see citing works
Effects of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT
Charman, W. N., & Stella, V. J. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90050-5 · Cited by 75 · see citing works
Self-citationProcess characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid
Hansen, T., Holm, P., & Schultz, K. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.014 · Cited by 75 · see citing works
Solubilizing Properties of Bile Salt Solutions II.
Bates, T. R., Gibaldi, M., & Kanig, J. L. (1966) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600550906 · Cited by 73 · see citing works
Sek, L., Boyd, B. J., Charman, W. N., & Porter, C. J. H. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.6.0011 · Cited by 72 · see citing works
Self-citationN’Goma, J. B., Williams, H. D., Sassene, P. J., Kleberg, K., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1532-y · Cited by 72 · see citing works
Self-citationKhan, J., Rades, T., & Boyd, B. J. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1829-5 · Cited by 72 · see citing works
Jantratid, E., Janssen, N., Chokshi, H. P., Tang, K., & Dressman, J. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.12.010 · Cited by 71 · see citing works
High-Fat Meals Increase the Clearance of Cyclosporine
Gupta, S. K., & Benet, L. Z. (1990) · Pharmaceutical Research · doi:10.1023/a:1015831408425 · Cited by 68 · see citing works
Crum, M., Trevaskis, N. L., Williams, H. D., Pouton, C. W., & Porter, C. J. H. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1843-7 · Cited by 68 · see citing works
Self-citationSassene, P. J., Kleberg, K., Williams, H. D., N’Goma, J. B., Carrière, F., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., et al. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9672-x · Cited by 68 · see citing works
Self-citation
Flagged first, then by citations
4 of the 289 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [52]52. R.G. Strickley, Currently Marketed Oral Lipid-Based Dosage Forms, Oral Lipid-Based Formulations, CRC Press2007, pp. 1-31.
- [126]126. K.A. Milton, G. Edwards, S.A. Ward, M.I. Orme, A.M. Breckenridge, The effect of food on the pharacokinetics of halofantrine in man after the administration of a single oral dose, British Journal of Clinical Pharmacology, 27 (1989) P671- P672.
Cited by
Sorted by citations
Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine
Egorova, K. S., Gordeev, E. G., & Ananikov, V. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00562 · Cited by 1,666 · see citing works
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Montoto, S. S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 672 · see citing works
Techniques for Formulation of Nanoemulsion Drug Delivery System: A Review
Kumar, M., Bishnoi, R. S., Shukla, A. K., & Jain, C. P. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.3.225 · Cited by 459 · see citing works
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop‐Schnürch, A., Shrestha, N., Véronique Préat, A., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 374 · see citing works
Self-citationLee, M.-K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030264 · Cited by 347 · see citing works
Buya, A. B., Beloqui, A., Memvanga, P. B., & Véronique Préat, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 325 · see citing works
Zhang, X., Xing, H., Zhao, Y., & Ma, Z. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030074 · Cited by 296 · see citing works
Jeliński, T., Przybyłek, M., & Cysewski, P. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2643-2 · Cited by 267 · see citing works
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Pilkington, E. H., Suys, E. J. A., Trevaskis, N. L., Wheatley, A. K., Zukancic, D., Algarni, A., Al-Wassiti, H. A., Davis, T. P., Pouton, C. W., Kent, S. J., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.023 · Cited by 265 · see citing works
Self-citationCurrent approaches in lipid-based nanocarriers for oral drug delivery
Plaza-Oliver, M., Santander-Ortega, M. J., & Lozano, M. V. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00908-7 · Cited by 260 · see citing works
Bergström, C. A. S., & Larsson, P. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.044 · Cited by 246 · see citing works
Self-citationAn update on oral drug delivery via intestinal lymphatic transport
Zhang, Z., Lü, Y., Qi, J., & Wu, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.022 · Cited by 242 · see citing works
Self-emulsifying drug delivery systems: a novel approach to deliver drugs
Salawi, A. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2083724 · Cited by 234 · see citing works
Solubilization techniques used for poorly water-soluble drugs
Xie, B., Liu, Y., Li, X., Yang, P., & He, W. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.08.027 · Cited by 230 · see citing works
Review and analysis of FDA approved drugs using lipid-based formulations
Savla, R., Browne, J., Plassat, V., Wasan, K. M., & Wasan, E. K. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1342654 · Cited by 225 · see citing works
Musakhanian, J., Rodier, J.-D., & Dave, M. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02282-0 · Cited by 200 · see citing works
Computational prediction of formulation strategies for beyond-rule-of-5 compounds
Bergström, C. A. S., Charman, W. N., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.005 · Cited by 190 · see citing works
Self-citationPharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs
Nyamba, I., Sombié, C. B., Yabré, M., Zimé-Diawara, H., Yaméogo, J. B. G., Ouédraogo, S., Lechanteur, A., Semdé, R., & Évrard, B. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114513 · Cited by 188 · see citing works
Charalabidis, A., Sfouni, M., Bergström, C. A. S., & Macheras, P. E. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.041 · Cited by 178 · see citing works
Self-citationApplication of Permeation Enhancers in Oral Delivery of Macromolecules: An Update
Maher, S., Brayden, D. J., Casettari, L., & Illum, L. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11010041 · Cited by 173 · see citing works
Novel strategies for the formulation and processing of poorly water-soluble drugs
Göke, K., Lorenz, T., Repanas, A., Schneider, F., Steiner, D., Baumann, K., Bunjes, H., Dietzel, A. H., Finke, J. H., Glasmacher, B., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.008 · Cited by 156 · see citing works
Self-Emulsifying Oral Lipid Drug Delivery Systems: Advances and Challenges
Rani, S., Rana, R., Saraogi, G. K., Kumar, V., & Gupta, U. D. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1335-x · Cited by 155 · see citing works
Vinarov, Z., Abrahamsson, B., Artursson, P., Batchelor, H. K., Berben, P., Bernkop‐Schnürch, A., Butler, J., Ceulemans, J., Davies, N. M., Dupont, D., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.001 · Cited by 155 · see citing works
Self-citationNanostructured lipid carriers: a promising drug carrier for targeting brain tumours
Garg, J., Pathania, K., Sah, S. P., & Pawar, S. V. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00414-8 · Cited by 149 · see citing works
Temperature- and rigidity-mediated rapid transport of lipid nanovesicles in hydrogels
Yu, M., Song, W., Tian, F., Dai, Z., Zhu, Q., Ahmad, E., Guo, S., Zhu, C., Zhong, H., Yuan, Y., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818924116 · Cited by 147 · see citing works
Ditzinger, F., Price, D. J., Ilie, A.-R., Koehl, N. J., Janković, S., Τσακιρίδου, Γ., Aleandri, S., Kalantzi, L., Holm, R., Nair, A., et al. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12984 · Cited by 144 · see citing works
Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos
Maji, I., Mahajan, S., Sriram, A., Medtiya, P., Vasave, R., Khatri, D. K., Kumar, R., Singh, S. B., Madan, J., & Singh, P. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.013 · Cited by 129 · see citing works
Singh, A., Neupane, Y. R., Mangla, B., & Kohli, K. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.06.003 · Cited by 128 · see citing works
Food for thought: formulating away the food effect – a PEARRL review
O’Shea, J. P., Holm, R., O’Driscoll, C. M., & Griffin, B. T. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12957 · Cited by 123 · see citing works
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges
Joyce, P., Dening, T. J., Meola, T. R., Schultz, H. B., Holm, R., Thomas, N., & Prestidge, C. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.006 · Cited by 122 · see citing works
Uttreja, P., Karnik, I., Youssef, A. A. A., Narala, N., Elkanayati, R. M., Baisa, S., Alshammari, N. D., Banda, S., Vemula, S. K., & Repka, M. A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010063 · Cited by 117 · see citing works
Krstić, M., Medarević, D. P., Djuriš, J., & Ibric, S. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813687-4.00012-8 · Cited by 115 · see citing works
Berthelsen, R., Klitgaard, M., Rades, T., & Müllertz, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.010 · Cited by 111 · see citing works
Do drug release studies from SEDDS make any sense?
Bernkop‐Schnürch, A., & Jalil, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.027 · Cited by 111 · see citing works
Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs
Mohite, P. B., Singh, S. K., Pawar, A. R., Sangale, A., & Prajapati, B. G. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1232012 · Cited by 111 · see citing works
Formulation strategies to improve the efficacy of intestinal permeation enhancers,
Maher, S., & Brayden, D. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113925 · Cited by 107 · see citing works
Lipid-based emulsion drug delivery systems — a comprehensive review
Dhaval, M., Vaghela, P., Patel, K., Sojitra, K., Patel, M., Patel, S., Dudhat, K. R., Shah, S. R., Manek, R. A., & Parmar, R. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01071-9 · Cited by 107 · see citing works
Mandić, J., Pobirk, A. Z., Vrečer, F., & Gašperlin, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.036 · Cited by 106 · see citing works
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems
Park, H., Ha, E., & Kim, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040365 · Cited by 105 · see citing works
Huang, Y., Yu, Q., Chen, Z., Wu, W., Zhu, Q., & Lü, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.025 · Cited by 104 · see citing works
Vithani, K., Jannin, V., Pouton, C. W., & Boyd, B. J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.008 · Cited by 101 · see citing works
Self-citationIn Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Cevaal, P. M., Ali, A., Czuba‐Wojnilowicz, E., Symons, J., Lewin, S. R., Cortez‐Jugo, C., & Caruso, F. (2021) · ACS Nano · doi:10.1021/acsnano.0c09514 · Cited by 100 · see citing works
Izgelov, D., Shmoeli, E., Domb, A. J., & Hoffman, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119201 · Cited by 99 · see citing works
Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs
Beloqui, A., del Pozo‐Rodríguez, A., Isla, A., Rodríguez‐Gascón, A., & Solinís, M. Á. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.06.013 · Cited by 98 · see citing works
Improving solubility of poorly water-soluble drugs by protein-based strategy: A review
Liu, X., Zhao, L., Wu, B., & Chen, F. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122704 · Cited by 89 · see citing works
In vivo fate of lipid-based nanoparticles
Qi, J., Zhuang, J., Lü, Y., Dong, X., Zhao, W., & Wu, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.024 · Cited by 89 · see citing works
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Keemink, J., & Bergström, C. A. S. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2327-8 · Cited by 87 · see citing works
Self-citationPreparation of a solid self-microemulsifying drug delivery system by hot-melt extrusion
Silva, L. A. D., Almeida, S. L., Alonso, E. C. P., da Rocha, P. B. R., Martins, F. T., de Freitas, L. A. P., Taveira, S. F., Cunha‐Filho, M., & Marreto, R. N. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.02.020 · Cited by 86 · see citing works
Jeliński, T., Przybyłek, M., & Cysewski, P. (2019) · Figshare · doi:10.6084/m9.figshare.8230628 · Cited by 85 · see citing works
Jin, Q. Y., Meng, H., Xin, L., Xia, M., Shen, H., Li, G., & Xie, Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.09.020 · Cited by 85 · see citing works
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Keemink, J., Mårtensson, E., & Bergström, C. A. S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00811 · Cited by 82 · see citing works
Self-citationStegemann, S., Moreton, C., Svanbäck, S., Box, K. J., Motte, G., & Paudel, A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103344 · Cited by 81 · see citing works
Lipid-Based Oral Formulation Strategies for Lipophilic Drugs
Patel, V., Lalani, R., Bardoliwala, D., Ghosh, S., & Misra, A. R. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1188-8 · Cited by 80 · see citing works
Structured edible lipid-based particle systems for oral drug-delivery
Ashkar, A., Sosnik, A., & Davidovich‐Pinhas, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107789 · Cited by 78 · see citing works
Mahadev, M., Nandini, H. S., Ramu, R., Gowda, D. V., Almarhoon, Z. M., Al-Ghorbani, M., & Mabkhot, Y. N. (2022) · Pharmaceuticals · doi:10.3390/ph15010070 · Cited by 75 · see citing works
Morais, R. A., Teixeira, G. L., Ferreira, S. R. S., Cifuentes, A., & Block, J. M. (2022) · Nutrients · doi:10.3390/nu14194009 · Cited by 74 · see citing works
Quan, G., Niu, B., Singh, V., Zhou, Y., Wu, C., Pan, X., & Wu, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s149717 · Cited by 72 · see citing works
Maher, S., Geoghegan, C., & Brayden, D. J. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1825375 · Cited by 71 · see citing works
Holm, R., Kuentz, M., Ilie, A.-R., & Griffin, B. T. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106556 · Cited by 69 · see citing works
Alskär, L. C., Keemink, J., Johannesson, J., Porter, C. J. H., & Bergström, C. A. S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00699 · Cited by 68 · see citing works
Self-citationLipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications
Harshita, Barkat, M. A., Das, S. S., Pottoo, F. H., Beg, S., & Rahman, Z. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200206094529 · Cited by 68 · see citing works
Jiang, W., Chen, J., Gong, C., Wang, Y., Gao, Y., & Yuan, Y. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00607-4 · Cited by 67 · see citing works
3D printing of pharmaceutical dosage forms: Recent advances and applications
Auel, T., Mentrup, A. F. C., Oldfield, L. R., & Seidlitz, A. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115504 · Cited by 67 · see citing works
Sahbaz, Y., Nguyen, T., Ford, L., McEvoy, C. L., Williams, H. D., Scammells, P. J., & Porter, C. J. H. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00442 · Cited by 67 · see citing works
Self-citationMicrogels and Nanogels for the Delivery of Poorly Water-Soluble Drugs
Dave, R., Randhawa, G., Kim, D., Simpson, M. J., & Hoare, T. R. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00967 · Cited by 65 · see citing works
Lipids in the Stomach – Implications for the Evaluation of Food Effects on Oral Drug Absorption
Koziolek, M., Carrière, F., & Porter, C. J. H. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2289-x · Cited by 65 · see citing works
Self-citationSuys, E. J. A., Chalmers, D. K., Pouton, C. W., & Porter, C. J. H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00206 · Cited by 63 · see citing works
Self-citationBeig, A., Fine‐Shamir, N., Lindley, D., Miller, J. M., & Dahan, A. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0052-1 · Cited by 61 · see citing works
Williams, H. D., Ford, L., Han, S., Tangso, K. J., Lim, S. F., Shackleford, D. M., Vodak, D. T., Benameur, H., Pouton, C. W., Scammells, P. J., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00858 · Cited by 61 · see citing works
Self-citationUnlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms
Williams, H. D., Ford, L., Igonin, A., Shan, Z., Botti, P., Morgen, M. M., Hu, G., Pouton, C. W., Scammells, P. J., Porter, C. J. H., et al. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.008 · Cited by 60 · see citing works
Self-citationSchultz, H. B., Meola, T. R., Thomas, N., & Prestidge, C. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119069 · Cited by 60 · see citing works
Lipid-Based Nanocarriers for the Oral Administration of Biopharmaceutics
Karamanidou, T., Bourganis, V., Kammona, O., & Kiparissides, C. A. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0265 · Cited by 59 · see citing works
Holm, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.009 · Cited by 59 · see citing works
Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport
Elz, A. S., Trevaskis, N. L., Porter, C. J. H., Bowen, J. M., & Prestidge, C. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.003 · Cited by 58 · see citing works
Self-citationSawicki, E., Schellens, J. H. M., Beijnen, J. H., & Nuijen, B. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.09.012 · Cited by 58 · see citing works
Prajapat, M. D., Patel, N. J., Bariya, A. H., Patel, S. S., & Butani, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.02.002 · Cited by 58 · see citing works
Sketching neoteric solvents for boosting drugs bioavailability
Álvarez, M. S., & Zhang, Y. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.09.008 · Cited by 57 · see citing works
Syed, M. H., Zahari, M. A. K. M., Khan, M. M. R., Beg, M. D. H., & Abdullah, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104121 · Cited by 56 · see citing works
Boyd, B. J., Salim, M., Clulow, A. J., Ramirez, G., Pham, A. C., & Hawley, A. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.027 · Cited by 56 · see citing works
Technologies to Improve the Solubility, Dissolution and Bioavailability of Poorly Soluble Drugs
Kanikkannan, N. (2018) · Journal of Analytical & Pharmaceutical Research · doi:10.15406/japlr.2018.07.00198 · Cited by 54 · see citing works
Tang, Y., Liu, B., Zhang, Y., Liu, Y., Huang, Y., & Fan, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115304 · Cited by 53 · see citing works
Koehl, N. J., Holm, R., Kuentz, M., Jannin, V., & Griffin, B. T. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00305 · Cited by 52 · see citing works
Chaturvedi, S., Garg, A., & Verma, A. K. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101899 · Cited by 51 · see citing works
Frueh, L., Li, Y., Mather, M. W., Li, Q., Pou, S., Nilsen, A., Winter, R. W., Forquer, I., Pershing, A. M., Xie, L. H., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00062 · Cited by 50 · see citing works
Prá, M. A. A. D., Vardanega, R., & Loss, C. G. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121159 · Cited by 49 · see citing works
Schultz, H. B., Thomas, N., Rao, S., & Prestidge, C. A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.12.012 · Cited by 48 · see citing works
Jain, A., Kaur, R., Beg, S., Kushwah, V., Jain, S., & Singh, B. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0514-8 · Cited by 47 · see citing works
Lin, P., Chen, K., Miao, Y., Chen, H., Lin, K., Chen, C., Yeh, C., Chang, Y., & Sung, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201809015 · Cited by 47 · see citing works
Tay, E., Nguyen, T., Ford, L., Williams, H. D., Benameur, H., Scammells, P. J., & Porter, C. J. H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010017 · Cited by 47 · see citing works
Self-citationMatrix systems for oral drug delivery: Formulations and drug release
Vasvári, G., Kalmár, J., Veres, P., Vecsernyés, M., Bácskay, I., Fehér, P. S., Ujhelyi, Z., Haimhoffer, Á., Rusznyák, Á., Fenyvesi, F., et al. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.06.009 · Cited by 46 · see citing works
Quantification of the Quercetin Nanoemulsion Technique Using Various Parameters
Sah, M. K., Gautam, B., Pokhrel, K. P., Ghani, L., & Bhattarai, A. (2023) · Molecules · doi:10.3390/molecules28062540 · Cited by 44 · see citing works
Dening, T. J., Joyce, P., Rao, S., Thomas, N., & Prestidge, C. A. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b13599 · Cited by 44 · see citing works
Jeliński, T., Przybyłek, M., & Cysewski, P. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1597104 · Cited by 44 · see citing works
McClements, D. J. (2020) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032519-051834 · Cited by 44 · see citing works
Đekić, L., Janković, J., Čalija, B. R., & Primorac, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.028 · Cited by 43 · see citing works
Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin
Doreth, M., Löbmann, K., Priemel, P. A., Grohganz, H., Taylor, R. J., Holm, R., de Diego, H. L., & Rades, T. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.10.001 · Cited by 43 · see citing works
Vasoya, J. M., Desai, H. H., Gumaste, S. G., Tillotson, J., Kelemen, D. W., Dalrymple, D. M., & Serajuddin, A. T. M. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.09.019 · Cited by 43 · see citing works
Drug supersaturation during formulation digestion, including real-time analytical approaches
Kuentz, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.003 · Cited by 43 · see citing works
Feng, W., Qin, C., Chu, Y., Berton, M., Lee, J. B., Zgair, A., Bettonte, S., Stocks, M. J., Constantinescu, C. S., Barrett, D. A., et al. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.02.013 · Cited by 43 · see citing works
Stable and Fast-Dissolving Amorphous Drug Composites Preparation via Impregnation of Neusilin® UFL2
Azad, M. A., Moreno, J., & Davé, R. N. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.10.007 · Cited by 42 · see citing works
- Authors
- Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H.
- Affiliations
- Monash University (AU)
- Uppsala University (SE)
- Corresponding author
- Porter, Christopher J.H.
- ORCID
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 101
- Pages
- 167-194
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2339649458
- Cited by
- 426
- References
- 289
- Citations by year
- 2026: 28 · 2025: 45 · 2024: 43 · 2023: 39 · 2022: 50 · 2021: 46 · 2020: 63 · 2019: 33 · 2018: 41 · 2017: 27 · 2016: 10
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- green
- research.monash.edu
- Licence
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Funders
- Australian Research Council (CE140100036, DP110103969)
- National Health and Medical Research Council (00010544)
- Capsugel
- Lipid Formulation Classification System (LFCS) Consortium
- Pfizer and GSK
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- lipid-based formulations, oral drug absorption, poorly water-soluble drugs, supersaturation, dissolution enhancement, in vitro digestion, in vitro-in vivo correlation, ionic liquids, prodrugs, gelatin capsules, pharmaceutical excipients, drug-metabolizing enzymes, drug permeability
- MeSH terms
- Administration, Oral, Drug Compounding, Pharmaceutical Preparations, Emulsions, Lipids, Fenofibrate, Solubility, Drug Delivery Systems, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review